BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially ...

Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer while it works to fend off activist criticism that its pipeline is underwhelming. Boshoff ...

Pfizer PFE1.44%increase; green up pointing triangle elevated the executive in charge of its cancer-drugs business to oversee all of the drugmaker’s research and development, a crucial move at a ...

Pfizer has found a successor for Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the company’s own Chris Boshoff, M.D., Ph.D., for the job and prompting a domino ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD ...

Pfizer on Wednesday said it will promote Chris Boshoff to chief scientific officer and president of research and development as the giant drugmaker struggles to win back the faith of investors.

Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for lung cancer and obesity, adding to collaborations it formed with other Flagship startups earlier this year.

Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties overseeing the company’s ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, positioning both companies to compete for that market and laying down a marker for ...

NEW YORK, Nov 19 (Reuters) - A federal judge on Tuesday rejected Pfizer's (PFE.N), opens new tab bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission insider ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer recently talked about. On Thursday, Jim Cramer, host of Mad Money ...

New York-based Pfizer markets a wide range of drugs and vaccines. Pfizer’s Biopharma reporting segment includes three broad therapeutic areas, Primary Care (Internal Medicine, Vaccines ...